Issue
Date Log
Copyright (c) 2026 Safa Mohammed Khard, Nawal Ibrahim Ali Al-Thurwi, Amnah Mabar Majashi, Hasinah Mohsen Shaddadi, Sheikha Ahmed Ali Dagas, Najoud Zain Al Hadi, Marwah Essa Ahmed Romedi, Salihah Mohammed Hussein Tumayhi, Basmah Mousa Yousef Shiply, Tahani Alallah Hassan Hakami, Hanan Mohamed Ahmed Ahmed, Wejdan Zaid Almodeerr

This work is licensed under a Creative Commons Attribution 4.0 International License.
The Contribution of Health Information Professionals, Public Health Specialists, and Medical Secretaries to Cardiovascular Disease Prevention Programs.
Corresponding Author(s) : Safa Mohammed Khard
Saudi Journal of Medicine and Public Health,
Vol. 3 No. 1 (2026)
Abstract
Background: Cardiovascular disease (CVD) remains a leading cause of morbidity and mortality among older adults in Europe. Population ageing has increased the burden of cardiovascular conditions and highlighted challenges related to multimorbidity, frailty, cognitive impairment, and inequalities in healthcare access. However, older individuals remain underrepresented in clinical research, limiting the evidence available to guide their management.
Aim: This review examines the epidemiology, diagnostic challenges, treatment limitations, and prevention of CVD among older adults in Europe, with particular attention to frailty, rehabilitation, social inequalities, and multidisciplinary healthcare delivery.
Methods: A narrative review of the available literature was conducted to discuss demographic trends, cardiovascular risk factors, clinical presentations, diagnostic approaches, pharmacological and invasive treatments, lifestyle interventions, and healthcare-related outcomes in older populations.
Results: CVD prevalence and associated healthcare demands increase with advancing age. Underrepresentation in randomized clinical trials limits the applicability of treatment recommendations to older patients. Age-related physiological changes, atypical symptoms, and limitations in cardiovascular risk prediction complicate diagnosis. Multimorbidity, polypharmacy, and cognitive impairment further influence treatment safety and adherence. Evidence regarding invasive cardiovascular interventions in frail older patients remains mixed, supporting individualized treatment decisions. Prevention requires appropriate pharmacological management, nutritional support, smoking cessation, and physical activity. Frailty assessment and cardiac rehabilitation can support functional independence. Socioeconomic disadvantage, geographical barriers, and social isolation further contribute to inequalities in cardiovascular outcomes.
Conclusion: Effective cardiovascular care requires an integrated approach that considers biological ageing, functional status, comorbidities, and patient preferences. Greater inclusion of older adults in clinical trials and stronger multidisciplinary services are essential to improve outcomes and reduce inequalities
Keywords
Download Citation
Endnote/Zotero/Mendeley (RIS)BibTeX
- 1. United Nations. UN decade of healthy ageing: plan of action (2021-2030). New York, NY, USA: United Nations; 2021.
- 2. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022;e068208.
- 3. Karadavut S, Altintop I. Long-term cardiovascular adverse events in very elderly COVID-19 patients. Arch Gerontol Geriatr. 2022;100:104628.
- 4. EU. Ageing Europe: looking at the lives of older people in the EU, 2020 edition. Luxembourg: Publications Office of the European Union; 2020.
- 5. Timmis A, Aboyans V, Vardas P, et al. European Society of Cardiology: the 2023 atlas of cardiovascular disease statistics. Eur Heart J. 2024;27:ehae466.
- 6. Timmis A, Kazakiewicz D, Torbica A, et al. Cardiovascular disease care and outcomes in West and South European countries. Lancet Reg Health Eur. 2023;33:100718.
- 7. Morseth B, Geelhoed B, Linneberg A, et al. Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium. Open Heart. 2021;8(2):e001624.
- 8. Goldhaber SZ, Bassand JP, Camm AJ, et al. Clinical outcomes in older patients with atrial fibrillation: insights from the GARFIELD-AF registry. Am J Med. 2024;137(2):128-136.e13.
- 9. Garred CH, Malmborg M, Malik ME, et al. Age-specific mortality trends in heart failure over 25 years: a retrospective Danish nationwide cohort study. Lancet Healthy Longev. 2024;5(5):e326-e335.
- 10. Martinelli E, Di Stefano A, Gareri P, et al. Heart failure in elderly people: from pathophysiology to diagnosis and management. OBM Geriatr. 2023;7(3):1-26.
- 11. Asaria P, Bennett JE, Elliott P, et al. Contributions of event rates, pre-hospital deaths, and deaths following hospitalisation to variations in myocardial infarction mortality in 326 districts in England: a spatial analysis of linked hospitalisation and mortality data. Lancet Public Health. 2022;7(10):e813-e824.
- 12. Hsu J, Iversen T, Price M, et al. Myocardial infarction care among the elderly: declining treatment with increasing age in two countries: study examines myocardial infarction among the elderly in the US and Norway. Health Aff. 2021;40(9):1483-1490.
- 13. Gattringer T, Posekany A, Niederkorn K, et al. Predicting early mortality of acute ischemic stroke: score-based approach. Stroke. 2019;50(2):349-356.
- 14. Beuker C, Köppe J, Feld J, et al. Association of age with 1-year outcome in patients with acute ischaemic stroke treated with thrombectomy: real-world analysis in 18 506 patients. J Neurol Neurosurg Psychiatry. 2023;94(8):631-637.
- 15. El Husseini N, Katzan IL, Rost NS, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2023;54(6).
- 16. van Marum RJ. Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol. 2020;86(10):2014-2016.
- 17. Nguyen D, Mika G, Ninh A. Age-based exclusions in clinical trials: a review and new perspectives. Contemp Clin Trials. 2022;114:106683.
- 18. Rich MW, Chyun DA, Skolnick AH, et al. Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. Circulation. 2016;133(21):2103-2122.
- 19. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337.
- 20. Zannad F, Berwanger O, Corda S, et al. How to make cardiology clinical trials more inclusive. Nat Med. 2024;30(10):2745-2755.
- 21. Khan SU, Khan MZ, Raghu Subramanian C, et al. Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: a systematic review. JAMA Netw Open. 2020;3(5):e205202.
- 22. Neumann JT, Thao LTP, Callander E, et al. Cardiovascular risk prediction in healthy older people. Geroscience. 2022;44(1):403-413.
- 23. De Vries TI, Cooney MT, Selmer RM, et al. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455-2467.
- 24. Nanna MG, Peterson ED, Wojdyla D, et al. The accuracy of cardiovascular pooled cohort risk estimates in U.S. older adults. J Gen Intern Med. 2020;35(6):1701-1708.
- 25. Strandberg TE. Challenges of treating cardiovascular risk in old age. Lancet Healthy Longev. 2021;2(6):e308-e309.
- 26. Brugts JJ, Knetsch AM, Mattace-Raso FUS, et al. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study. Arch Intern Med. 2005;165(22):2659.
- 27. Hussein M, Diez Roux AV, Mujahid MS, et al. Unequal exposure or unequal vulnerability? Contributions of neighborhood conditions and cardiovascular risk factors to socioeconomic inequality in incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2018;187(7):1424-1437.
- 28. Lang SJ, Abel GA, Mant J, et al. Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study. BMJ Open. 2016;6(3):e009984.
- 29. Priscilla P, Coţe IA, Popescu MI. Acute coronary syndromes in the elderly: impact of age on diagnosis and therapeutic management. Intern Med. 2019;16(1):59-66.
- 30. Engberding N, Wenger NK. Acute coronary syndromes in the elderly. F1000Res. 2017;6:1791.
- 31. Grosmaitre P, Le Vavasseur O, Yachouh E, et al. Significance of atypical symptoms for the diagnosis and management of myocardial infarction in elderly patients admitted to emergency departments. Arch Cardiovasc Dis. 2013;106(11):586-592.
- 32. Ladapo JA, Budoff MJ, Sharp D, et al. Utility of a precision medicine test in elderly adults with symptoms suggestive of coronary artery disease. J Am Geriatr Soc. 2018;66(2):309-315.
- 33. Kozlov SG, Chernova OV, Gerasimova EV, et al. Noninvasive testing for diagnosis of stable coronary artery disease in the elderly. Int J Mol Sci. 2020;21(17):6263.
- 34. Drenth-van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people: how to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921-1930.
- 35. Dunlay SM, Chamberlain AM. Multimorbidity in older patients with cardiovascular disease. Curr Cardiovasc Risk Rep. 2016;10(1):3.
- 36. Van Der Luit CD, De Jong IR, Ebbens MM, et al. Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission. Pharm Pract. 2018;16(4):1301.
- 37. Pernias V, García Acuña JM, Raposeiras-Roubín S, et al. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS. REC Interv Cardiol Engl. 2022;4503.
- 38. Sheikh-Taha M, Asmar M. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. BMC Geriatr. 2021;21(1):233.
- 39. Patel S, Kumar M, Beavers CJ, et al. Polypharmacy and cardiovascular diseases: consideration for older adults and women. Curr Atheroscler Rep. 2022;24(10):813-820.
- 40. Zhou M, Zhao G, Zeng Y, et al. Aging and cardiovascular disease: current status and challenges. Rev Cardiovasc Med. 2022;23(4):135.
- 41. Andrade A, Nascimento T, Cabrita C, et al. Potentially inappropriate medication: a pilot study in institutionalized older adults. Healthcare. 2024;12(13):1275.
- 42. Alexander M, Perera G, Ford L, et al. Age-stratified prevalence of mild cognitive impairment and dementia in European populations: a systematic review. J Alzheimers Dis. 2015;48(2):355-359.
- 43. Farnsworth Von Cederwald B, Josefsson M, Wåhlin A, et al. Association of cardiovascular risk trajectory with cognitive decline and incident dementia. Neurology. 2022;98(20).
- 44. Thorsteinsson K, Fonager K, Mérie C, et al. Age-dependent trends in postoperative mortality and preoperative comorbidity in isolated coronary artery bypass surgery: a nationwide study. Eur J Cardiothorac Surg. 2016;49(2):391-397.
- 45. Ceylan İ, Mhmood AH, Al-Janabi RQK. Effects of early mobilization in elderly patients undergoing cardiac surgery. Ir J Med Sci. 2024;193.
- 46. Lemaire A, Soto C, Salgueiro L, et al. The impact of age on outcomes of coronary artery bypass grafting. J Cardiothorac Surg. 2020;15(1):158.
- 47. Reisman AM, Farrell K, Leitman IM. Cost comparison of elective invasive procedures between elderly and non-elderly patients at an academic medical center. J Sci Innov Med. 2019;2(1):3.
- 48. Biscaglia S, Guiducci V, Escaned J, et al. Complete or culprit-only PCI in older patients with myocardial infarction. N Engl J Med. 2023;389(10):889-898.
- 49. Kunadian V, Mossop H, Shields C, et al. Invasive treatment strategy for older patients with myocardial infarction. N Engl J Med. 2024;391(18):1673-1684.
- 50. Sanchis J, Bueno H, Miñana G, et al. Effect of routine invasive vs conservative strategy in older adults with frailty and non-ST-segment elevation acute myocardial infarction: a randomized clinical trial. JAMA Intern Med. 2023;183(5):407.
- 51. Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet. 2016;387(10023):1057-1065.
- 52. Kotanidis CP, Mills GB, Bendz B, et al. Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis. Eur Heart J. 2024;45(23):2052-2062.
- 53. Belmin J, Chauvelier S, Friocourt P. [Prevention of coronary heart disease and heart failure in the elderly]. Rev Prat. 2009;59(10):1389-1395.
- 54. Kim KI. Risk stratification of cardiovascular disease according to age groups in new prevention guidelines: a review. J Lipid Atheroscler. 2023;12(2):96.
- 55. Makover ME, Shapiro MD, Toth PP. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: a review of current practice and recommendations for improved effectiveness. Am J Prev Cardiol. 2022;12:100371.
- 56. Biros E, Karan M, Golledge J. Genetic variation and atherosclerosis. Curr Genomics. 2008;9(1):29-42.
- 57. Forman DE, de Lemos JA, Shaw LJ, et al. Cardiovascular biomarkers and imaging in older adults: JACC council perspectives. J Am Coll Cardiol. 2020;76(13):1577-1594.
- 58. Horodinschi RN, Stanescu AMA, Bratu OG, et al. Treatment with statins in elderly patients. Medicina. 2019;55(11):721.
- 59. Mihaylova B, Wu R, Zhou J, et al. Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study. Heart. 2024;110(21):1277-1285.
- 60. McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379(16):1499-1508.
- 61. Çetinkaya PD, Turan A, Deniz PP, et al. Smoking cessation success and affecting factors in geriatric patients. Iran J Public Health. 2023;52.
- 62. Taylor DH, Hasselblad V, Henley SJ, et al. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92(6):990-996.
- 63. Cereda E, Pedrolli C, Klersy C, et al. Nutritional status in older persons according to healthcare setting: a systematic review and meta-analysis of prevalence data using MNA®. Clin Nutr. 2016;35(6):1282-1290.
- 64. Leij-Halfwerk S, Verwijs MH, Van Houdt S, et al. Prevalence of protein-energy malnutrition risk in European older adults in community, residential and hospital settings, according to 22 malnutrition screening tools validated for use in adults ≥65 years. Maturitas. 2019;126:80-89.
- 65. WHO EURO. Promoting physical activity and healthy diets for healthy ageing in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2023.
- 66. WHO. WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization; 2020.
- 67. Valenzuela PL, Saco-Ledo G, Morales JS, et al. Effects of physical exercise on physical function in older adults in residential care: a systematic review and network meta-analysis of randomised controlled trials. Lancet Healthy Longev. 2023;4(6):e247-e256.
- 68. Eurostat. Health-enhancing physical activity statistics. Luxembourg: European Union; 2022.
- 69. Patrono C, Baigent C. Role of aspirin in primary prevention of cardiovascular disease. Nat Rev Cardiol. 2019;16(11):675-686.
- 70. Eggink E, Hafdi M, Hoevenaar-Blom MP, et al. Attitudes and views on healthy lifestyle interventions for the prevention of dementia and cardiovascular disease among older people with low socioeconomic status: a qualitative study in the Netherlands. BMJ Open. 2022;12(2):e055984.
- 71. Forman DE, Kuchel GA, Newman JC, et al. Impact of geroscience on therapeutic strategies for older adults with cardiovascular disease. J Am Coll Cardiol. 2023;82(7):631-647.
- 72. Pitter JG, Zemplényi A, Babarczy B, et al. Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe. Geroscience. 2023;46(2):1807-1824.
- 73. Manfredi G, Midão L, Paúl C, et al. Prevalence of frailty status among the European elderly population: findings from the Survey of Health, Ageing and Retirement in Europe. Geriatr Gerontol Int. 2019;19(8):723-729.
- 74. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63(8):747-762.
- 75. Welstead M, Jenkins ND, Russ TC, et al. A systematic review of frailty trajectories: their shape and influencing factors. Gerontologist. 2021;61(8):e463-e475.
- 76. Damluji AA, Alfaraidhy M, AlHajri N, et al. Sarcopenia and cardiovascular diseases. Circulation. 2023;147(20):1534-1553.
- 77. Ekerstad N, Swahn E, Janzon M, et al. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation. 2011;124(22):2397-2404.
- 78. Veronese N, Cereda E, Stubbs B, et al. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis. Ageing Res Rev. 2017;35:63-73.
- 79. Jiménez-Méndez C, Díez-Villanueva P, Bonanad C, et al. Frailty and prognosis of older patients with chronic heart failure. Rev Esp Cardiol. 2022;75(12):1011-1019.
- 80. Ijaz N, Buta B, Xue QL, et al. Interventions for frailty among older adults with cardiovascular disease. J Am Coll Cardiol. 2022;79(5):482-503.
- 81. Murphy A, Koshy A, Meehan G, et al. TCT-646 markers of frailty predict conservative management in very elderly (>85 years) patients presenting with non-ST-segment elevation myocardial infarction (NSTEMI). J Am Coll Cardiol. 2019;74(13):B634.
- 82. Doll JA, Hellkamp A, Ho PM, et al. Participation in cardiac rehabilitation programs among older patients after acute myocardial infarction. JAMA Intern Med. 2015;175(10):1700.
- 83. Zaman MJ, Kwok CS, Bachmann MO, et al. Explaining inequalities in receipt of care in the older patient with acute coronary syndrome. Eur Heart J Qual Care Clin Outcomes. 2016;2(2):59-61.
- 84. Hecker SM, Sade RM. Ethical issues in cardiothoracic surgery for the elderly. In: Katlic M, editor. Cardiothoracic Surgery in the Elderly. New York: Springer; 2011:89-103.
- 85. Fried TR. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med. 2011;171(20):1856.
- 86. Lettino M, Mascherbauer J, Nordaby M, et al. Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology cardiovascular round table. Eur J Prev Cardiol. 2022;29(10):1412-1424.
- 87. Karlsson C, Berggren I. Dignified end-of-life care in the patients’ own homes. Nurs Ethics. 2011;18(3):374-385.
- 88. Isenberg SR, Tanuseputro P, Spruin S, et al. Cost-effectiveness of investment in end-of-life home care to enable death in community settings. Med Care. 2020;58(8):665-673.
- 89. Krasniuk S, Crizzle AM. Impact of health and transportation on accessing healthcare in older adults living in rural regions. Transp Res Interdiscip Perspect. 2023;21:100882.
- 90. Fitzpatrick AL, Powe NR, Cooper LS, et al. Barriers to health care access among the elderly and who perceives them. Am J Public Health. 2004;94(10):1788-1794.
- 91. Tavares LP, Zantomio F. Inequity in healthcare use among older people after 2008: the case of southern European countries. Health Policy. 2017;121(10):1063-1071.
- 92. Helis E, Augustincic L, Steiner S, et al. Time trends in cardiovascular and all-cause mortality in the ‘old’ and ‘new’ European Union countries. Eur J Cardiovasc Prev Rehabil. 2011;18(3):347-359.
- 93. Vigorito C, Giallauria F. Loneliness, social isolation and risk of cardiovascular disease in the English Longitudinal Study of Ageing. Eur J Prev Cardiol. 2018;25(13):1384-1386.
- 94. Hu M, Patterson S. Late-life care for older adults: findings from NHATS and NSOC. Innov Aging. 2022;6(Supplement_1):418.
- 95. Petry SE, Lara L, Boucher NA. Older caregivers: who they are and how to support them. J Aging Soc Policy. 2024;36(4):589-602.
References
1. United Nations. UN decade of healthy ageing: plan of action (2021-2030). New York, NY, USA: United Nations; 2021.
2. Global, regional, and national burden of diseases and injuries for adults 70 years and older: systematic analysis for the Global Burden of Disease 2019 Study. BMJ. 2022;e068208.
3. Karadavut S, Altintop I. Long-term cardiovascular adverse events in very elderly COVID-19 patients. Arch Gerontol Geriatr. 2022;100:104628.
4. EU. Ageing Europe: looking at the lives of older people in the EU, 2020 edition. Luxembourg: Publications Office of the European Union; 2020.
5. Timmis A, Aboyans V, Vardas P, et al. European Society of Cardiology: the 2023 atlas of cardiovascular disease statistics. Eur Heart J. 2024;27:ehae466.
6. Timmis A, Kazakiewicz D, Torbica A, et al. Cardiovascular disease care and outcomes in West and South European countries. Lancet Reg Health Eur. 2023;33:100718.
7. Morseth B, Geelhoed B, Linneberg A, et al. Age-specific atrial fibrillation incidence, attributable risk factors and risk of stroke and mortality: results from the MORGAM Consortium. Open Heart. 2021;8(2):e001624.
8. Goldhaber SZ, Bassand JP, Camm AJ, et al. Clinical outcomes in older patients with atrial fibrillation: insights from the GARFIELD-AF registry. Am J Med. 2024;137(2):128-136.e13.
9. Garred CH, Malmborg M, Malik ME, et al. Age-specific mortality trends in heart failure over 25 years: a retrospective Danish nationwide cohort study. Lancet Healthy Longev. 2024;5(5):e326-e335.
10. Martinelli E, Di Stefano A, Gareri P, et al. Heart failure in elderly people: from pathophysiology to diagnosis and management. OBM Geriatr. 2023;7(3):1-26.
11. Asaria P, Bennett JE, Elliott P, et al. Contributions of event rates, pre-hospital deaths, and deaths following hospitalisation to variations in myocardial infarction mortality in 326 districts in England: a spatial analysis of linked hospitalisation and mortality data. Lancet Public Health. 2022;7(10):e813-e824.
12. Hsu J, Iversen T, Price M, et al. Myocardial infarction care among the elderly: declining treatment with increasing age in two countries: study examines myocardial infarction among the elderly in the US and Norway. Health Aff. 2021;40(9):1483-1490.
13. Gattringer T, Posekany A, Niederkorn K, et al. Predicting early mortality of acute ischemic stroke: score-based approach. Stroke. 2019;50(2):349-356.
14. Beuker C, Köppe J, Feld J, et al. Association of age with 1-year outcome in patients with acute ischaemic stroke treated with thrombectomy: real-world analysis in 18 506 patients. J Neurol Neurosurg Psychiatry. 2023;94(8):631-637.
15. El Husseini N, Katzan IL, Rost NS, et al. Cognitive impairment after ischemic and hemorrhagic stroke: a scientific statement from the American Heart Association/American Stroke Association. Stroke. 2023;54(6).
16. van Marum RJ. Underrepresentation of the elderly in clinical trials, time for action. Br J Clin Pharmacol. 2020;86(10):2014-2016.
17. Nguyen D, Mika G, Ninh A. Age-based exclusions in clinical trials: a review and new perspectives. Contemp Clin Trials. 2022;114:106683.
18. Rich MW, Chyun DA, Skolnick AH, et al. Knowledge gaps in cardiovascular care of the older adult population: a scientific statement from the American Heart Association, American College of Cardiology, and American Geriatrics Society. Circulation. 2016;133(21):2103-2122.
19. Visseren FLJ, Mach F, Smulders YM, et al. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice. Eur Heart J. 2021;42(34):3227-3337.
20. Zannad F, Berwanger O, Corda S, et al. How to make cardiology clinical trials more inclusive. Nat Med. 2024;30(10):2745-2755.
21. Khan SU, Khan MZ, Raghu Subramanian C, et al. Participation of women and older participants in randomized clinical trials of lipid-lowering therapies: a systematic review. JAMA Netw Open. 2020;3(5):e205202.
22. Neumann JT, Thao LTP, Callander E, et al. Cardiovascular risk prediction in healthy older people. Geroscience. 2022;44(1):403-413.
23. De Vries TI, Cooney MT, Selmer RM, et al. SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions. Eur Heart J. 2021;42(25):2455-2467.
24. Nanna MG, Peterson ED, Wojdyla D, et al. The accuracy of cardiovascular pooled cohort risk estimates in U.S. older adults. J Gen Intern Med. 2020;35(6):1701-1708.
25. Strandberg TE. Challenges of treating cardiovascular risk in old age. Lancet Healthy Longev. 2021;2(6):e308-e309.
26. Brugts JJ, Knetsch AM, Mattace-Raso FUS, et al. Renal function and risk of myocardial infarction in an elderly population: the Rotterdam Study. Arch Intern Med. 2005;165(22):2659.
27. Hussein M, Diez Roux AV, Mujahid MS, et al. Unequal exposure or unequal vulnerability? Contributions of neighborhood conditions and cardiovascular risk factors to socioeconomic inequality in incident cardiovascular disease in the Multi-Ethnic Study of Atherosclerosis. Am J Epidemiol. 2018;187(7):1424-1437.
28. Lang SJ, Abel GA, Mant J, et al. Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study. BMJ Open. 2016;6(3):e009984.
29. Priscilla P, Coţe IA, Popescu MI. Acute coronary syndromes in the elderly: impact of age on diagnosis and therapeutic management. Intern Med. 2019;16(1):59-66.
30. Engberding N, Wenger NK. Acute coronary syndromes in the elderly. F1000Res. 2017;6:1791.
31. Grosmaitre P, Le Vavasseur O, Yachouh E, et al. Significance of atypical symptoms for the diagnosis and management of myocardial infarction in elderly patients admitted to emergency departments. Arch Cardiovasc Dis. 2013;106(11):586-592.
32. Ladapo JA, Budoff MJ, Sharp D, et al. Utility of a precision medicine test in elderly adults with symptoms suggestive of coronary artery disease. J Am Geriatr Soc. 2018;66(2):309-315.
33. Kozlov SG, Chernova OV, Gerasimova EV, et al. Noninvasive testing for diagnosis of stable coronary artery disease in the elderly. Int J Mol Sci. 2020;21(17):6263.
34. Drenth-van Maanen AC, Wilting I, Jansen PAF. Prescribing medicines to older people: how to consider the impact of ageing on human organ and body functions. Br J Clin Pharmacol. 2020;86(10):1921-1930.
35. Dunlay SM, Chamberlain AM. Multimorbidity in older patients with cardiovascular disease. Curr Cardiovasc Risk Rep. 2016;10(1):3.
36. Van Der Luit CD, De Jong IR, Ebbens MM, et al. Frequency of occurrence of medication discrepancies and associated risk factors in cases of acute hospital admission. Pharm Pract. 2018;16(4):1301.
37. Pernias V, García Acuña JM, Raposeiras-Roubín S, et al. Impact of comorbidities in the decision of using invasive management in elderly patients with NSTEACS. REC Interv Cardiol Engl. 2022;4503.
38. Sheikh-Taha M, Asmar M. Polypharmacy and severe potential drug-drug interactions among older adults with cardiovascular disease in the United States. BMC Geriatr. 2021;21(1):233.
39. Patel S, Kumar M, Beavers CJ, et al. Polypharmacy and cardiovascular diseases: consideration for older adults and women. Curr Atheroscler Rep. 2022;24(10):813-820.
40. Zhou M, Zhao G, Zeng Y, et al. Aging and cardiovascular disease: current status and challenges. Rev Cardiovasc Med. 2022;23(4):135.
41. Andrade A, Nascimento T, Cabrita C, et al. Potentially inappropriate medication: a pilot study in institutionalized older adults. Healthcare. 2024;12(13):1275.
42. Alexander M, Perera G, Ford L, et al. Age-stratified prevalence of mild cognitive impairment and dementia in European populations: a systematic review. J Alzheimers Dis. 2015;48(2):355-359.
43. Farnsworth Von Cederwald B, Josefsson M, Wåhlin A, et al. Association of cardiovascular risk trajectory with cognitive decline and incident dementia. Neurology. 2022;98(20).
44. Thorsteinsson K, Fonager K, Mérie C, et al. Age-dependent trends in postoperative mortality and preoperative comorbidity in isolated coronary artery bypass surgery: a nationwide study. Eur J Cardiothorac Surg. 2016;49(2):391-397.
45. Ceylan İ, Mhmood AH, Al-Janabi RQK. Effects of early mobilization in elderly patients undergoing cardiac surgery. Ir J Med Sci. 2024;193.
46. Lemaire A, Soto C, Salgueiro L, et al. The impact of age on outcomes of coronary artery bypass grafting. J Cardiothorac Surg. 2020;15(1):158.
47. Reisman AM, Farrell K, Leitman IM. Cost comparison of elective invasive procedures between elderly and non-elderly patients at an academic medical center. J Sci Innov Med. 2019;2(1):3.
48. Biscaglia S, Guiducci V, Escaned J, et al. Complete or culprit-only PCI in older patients with myocardial infarction. N Engl J Med. 2023;389(10):889-898.
49. Kunadian V, Mossop H, Shields C, et al. Invasive treatment strategy for older patients with myocardial infarction. N Engl J Med. 2024;391(18):1673-1684.
50. Sanchis J, Bueno H, Miñana G, et al. Effect of routine invasive vs conservative strategy in older adults with frailty and non-ST-segment elevation acute myocardial infarction: a randomized clinical trial. JAMA Intern Med. 2023;183(5):407.
51. Tegn N, Abdelnoor M, Aaberge L, et al. Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty study): an open-label randomised controlled trial. Lancet. 2016;387(10023):1057-1065.
52. Kotanidis CP, Mills GB, Bendz B, et al. Invasive vs. conservative management of older patients with non-ST-elevation acute coronary syndrome: individual patient data meta-analysis. Eur Heart J. 2024;45(23):2052-2062.
53. Belmin J, Chauvelier S, Friocourt P. [Prevention of coronary heart disease and heart failure in the elderly]. Rev Prat. 2009;59(10):1389-1395.
54. Kim KI. Risk stratification of cardiovascular disease according to age groups in new prevention guidelines: a review. J Lipid Atheroscler. 2023;12(2):96.
55. Makover ME, Shapiro MD, Toth PP. There is urgent need to treat atherosclerotic cardiovascular disease risk earlier, more intensively, and with greater precision: a review of current practice and recommendations for improved effectiveness. Am J Prev Cardiol. 2022;12:100371.
56. Biros E, Karan M, Golledge J. Genetic variation and atherosclerosis. Curr Genomics. 2008;9(1):29-42.
57. Forman DE, de Lemos JA, Shaw LJ, et al. Cardiovascular biomarkers and imaging in older adults: JACC council perspectives. J Am Coll Cardiol. 2020;76(13):1577-1594.
58. Horodinschi RN, Stanescu AMA, Bratu OG, et al. Treatment with statins in elderly patients. Medicina. 2019;55(11):721.
59. Mihaylova B, Wu R, Zhou J, et al. Lifetime effects and cost-effectiveness of statin therapy for older people in the United Kingdom: a modelling study. Heart. 2024;110(21):1277-1285.
60. McNeil JJ, Woods RL, Nelson MR, et al. Effect of aspirin on disability-free survival in the healthy elderly. N Engl J Med. 2018;379(16):1499-1508.
61. Çetinkaya PD, Turan A, Deniz PP, et al. Smoking cessation success and affecting factors in geriatric patients. Iran J Public Health. 2023;52.
62. Taylor DH, Hasselblad V, Henley SJ, et al. Benefits of smoking cessation for longevity. Am J Public Health. 2002;92(6):990-996.
63. Cereda E, Pedrolli C, Klersy C, et al. Nutritional status in older persons according to healthcare setting: a systematic review and meta-analysis of prevalence data using MNA®. Clin Nutr. 2016;35(6):1282-1290.
64. Leij-Halfwerk S, Verwijs MH, Van Houdt S, et al. Prevalence of protein-energy malnutrition risk in European older adults in community, residential and hospital settings, according to 22 malnutrition screening tools validated for use in adults ≥65 years. Maturitas. 2019;126:80-89.
65. WHO EURO. Promoting physical activity and healthy diets for healthy ageing in the WHO European Region. Copenhagen: WHO Regional Office for Europe; 2023.
66. WHO. WHO guidelines on physical activity and sedentary behaviour. Geneva: World Health Organization; 2020.
67. Valenzuela PL, Saco-Ledo G, Morales JS, et al. Effects of physical exercise on physical function in older adults in residential care: a systematic review and network meta-analysis of randomised controlled trials. Lancet Healthy Longev. 2023;4(6):e247-e256.
68. Eurostat. Health-enhancing physical activity statistics. Luxembourg: European Union; 2022.
69. Patrono C, Baigent C. Role of aspirin in primary prevention of cardiovascular disease. Nat Rev Cardiol. 2019;16(11):675-686.
70. Eggink E, Hafdi M, Hoevenaar-Blom MP, et al. Attitudes and views on healthy lifestyle interventions for the prevention of dementia and cardiovascular disease among older people with low socioeconomic status: a qualitative study in the Netherlands. BMJ Open. 2022;12(2):e055984.
71. Forman DE, Kuchel GA, Newman JC, et al. Impact of geroscience on therapeutic strategies for older adults with cardiovascular disease. J Am Coll Cardiol. 2023;82(7):631-647.
72. Pitter JG, Zemplényi A, Babarczy B, et al. Frailty prevalence in 42 European countries by age and gender: development of the SHARE Frailty Atlas for Europe. Geroscience. 2023;46(2):1807-1824.
73. Manfredi G, Midão L, Paúl C, et al. Prevalence of frailty status among the European elderly population: findings from the Survey of Health, Ageing and Retirement in Europe. Geriatr Gerontol Int. 2019;19(8):723-729.
74. Afilalo J, Alexander KP, Mack MJ, et al. Frailty assessment in the cardiovascular care of older adults. J Am Coll Cardiol. 2014;63(8):747-762.
75. Welstead M, Jenkins ND, Russ TC, et al. A systematic review of frailty trajectories: their shape and influencing factors. Gerontologist. 2021;61(8):e463-e475.
76. Damluji AA, Alfaraidhy M, AlHajri N, et al. Sarcopenia and cardiovascular diseases. Circulation. 2023;147(20):1534-1553.
77. Ekerstad N, Swahn E, Janzon M, et al. Frailty is independently associated with short-term outcomes for elderly patients with non-ST-segment elevation myocardial infarction. Circulation. 2011;124(22):2397-2404.
78. Veronese N, Cereda E, Stubbs B, et al. Risk of cardiovascular disease morbidity and mortality in frail and pre-frail older adults: results from a meta-analysis and exploratory meta-regression analysis. Ageing Res Rev. 2017;35:63-73.
79. Jiménez-Méndez C, Díez-Villanueva P, Bonanad C, et al. Frailty and prognosis of older patients with chronic heart failure. Rev Esp Cardiol. 2022;75(12):1011-1019.
80. Ijaz N, Buta B, Xue QL, et al. Interventions for frailty among older adults with cardiovascular disease. J Am Coll Cardiol. 2022;79(5):482-503.
81. Murphy A, Koshy A, Meehan G, et al. TCT-646 markers of frailty predict conservative management in very elderly (>85 years) patients presenting with non-ST-segment elevation myocardial infarction (NSTEMI). J Am Coll Cardiol. 2019;74(13):B634.
82. Doll JA, Hellkamp A, Ho PM, et al. Participation in cardiac rehabilitation programs among older patients after acute myocardial infarction. JAMA Intern Med. 2015;175(10):1700.
83. Zaman MJ, Kwok CS, Bachmann MO, et al. Explaining inequalities in receipt of care in the older patient with acute coronary syndrome. Eur Heart J Qual Care Clin Outcomes. 2016;2(2):59-61.
84. Hecker SM, Sade RM. Ethical issues in cardiothoracic surgery for the elderly. In: Katlic M, editor. Cardiothoracic Surgery in the Elderly. New York: Springer; 2011:89-103.
85. Fried TR. Health outcome prioritization as a tool for decision making among older persons with multiple chronic conditions. Arch Intern Med. 2011;171(20):1856.
86. Lettino M, Mascherbauer J, Nordaby M, et al. Cardiovascular disease in the elderly: proceedings of the European Society of Cardiology cardiovascular round table. Eur J Prev Cardiol. 2022;29(10):1412-1424.
87. Karlsson C, Berggren I. Dignified end-of-life care in the patients’ own homes. Nurs Ethics. 2011;18(3):374-385.
88. Isenberg SR, Tanuseputro P, Spruin S, et al. Cost-effectiveness of investment in end-of-life home care to enable death in community settings. Med Care. 2020;58(8):665-673.
89. Krasniuk S, Crizzle AM. Impact of health and transportation on accessing healthcare in older adults living in rural regions. Transp Res Interdiscip Perspect. 2023;21:100882.
90. Fitzpatrick AL, Powe NR, Cooper LS, et al. Barriers to health care access among the elderly and who perceives them. Am J Public Health. 2004;94(10):1788-1794.
91. Tavares LP, Zantomio F. Inequity in healthcare use among older people after 2008: the case of southern European countries. Health Policy. 2017;121(10):1063-1071.
92. Helis E, Augustincic L, Steiner S, et al. Time trends in cardiovascular and all-cause mortality in the ‘old’ and ‘new’ European Union countries. Eur J Cardiovasc Prev Rehabil. 2011;18(3):347-359.
93. Vigorito C, Giallauria F. Loneliness, social isolation and risk of cardiovascular disease in the English Longitudinal Study of Ageing. Eur J Prev Cardiol. 2018;25(13):1384-1386.
94. Hu M, Patterson S. Late-life care for older adults: findings from NHATS and NSOC. Innov Aging. 2022;6(Supplement_1):418.
95. Petry SE, Lara L, Boucher NA. Older caregivers: who they are and how to support them. J Aging Soc Policy. 2024;36(4):589-602.